Exponent, Inc. (NASDAQ:EXPO – Get Free Report) VP Bradley A. James sold 3,528 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $335,160.00. Following the completion of the transaction, the vice president now directly owns 2,030 shares of the company’s stock, valued at approximately $192,850. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Exponent Trading Up 0.2 %
Exponent stock opened at $94.68 on Wednesday. The stock has a market cap of $4.79 billion, a P/E ratio of 47.82 and a beta of 0.64. The company has a fifty day simple moving average of $82.08 and a 200-day simple moving average of $82.07. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $102.72.
Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The business had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. During the same period in the previous year, the company earned $0.56 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. As a group, sell-side analysts forecast that Exponent, Inc. will post 1.92 earnings per share for the current fiscal year.
Exponent Dividend Announcement
Institutional Investors Weigh In On Exponent
Several hedge funds and other institutional investors have recently bought and sold shares of EXPO. New York State Teachers Retirement System raised its stake in Exponent by 2.6% during the 3rd quarter. New York State Teachers Retirement System now owns 40,168 shares of the business services provider’s stock worth $3,438,000 after acquiring an additional 1,020 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Exponent by 43.3% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,211 shares of the business services provider’s stock worth $1,131,000 after acquiring an additional 3,994 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in Exponent by 8.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 288,253 shares of the business services provider’s stock worth $24,674,000 after acquiring an additional 22,559 shares in the last quarter. Advisor Partners II LLC raised its stake in Exponent by 6.0% during the 3rd quarter. Advisor Partners II LLC now owns 3,771 shares of the business services provider’s stock worth $323,000 after acquiring an additional 215 shares in the last quarter. Finally, Park Avenue Securities LLC acquired a new stake in Exponent during the 3rd quarter worth $715,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities analysts have commented on EXPO shares. Truist Financial raised their price target on shares of Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. StockNews.com raised shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th.
View Our Latest Stock Report on EXPO
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- What Investors Need to Know to Beat the Market
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is a Bond Market Holiday? How to Invest and Trade
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Investing In Preferred Stock vs. Common Stock
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.